JP2015502356A5 - - Google Patents

Download PDF

Info

Publication number
JP2015502356A5
JP2015502356A5 JP2014544935A JP2014544935A JP2015502356A5 JP 2015502356 A5 JP2015502356 A5 JP 2015502356A5 JP 2014544935 A JP2014544935 A JP 2014544935A JP 2014544935 A JP2014544935 A JP 2014544935A JP 2015502356 A5 JP2015502356 A5 JP 2015502356A5
Authority
JP
Japan
Prior art keywords
antibody
reactivity
cross
less
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014544935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015502356A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/067353 external-priority patent/WO2013082463A2/en
Publication of JP2015502356A publication Critical patent/JP2015502356A/ja
Publication of JP2015502356A5 publication Critical patent/JP2015502356A5/ja
Pending legal-status Critical Current

Links

JP2014544935A 2011-11-30 2012-11-30 5−fuに関連するアッセイ、抗体、免疫原および組成物 Pending JP2015502356A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161565281P 2011-11-30 2011-11-30
US61/565,281 2011-11-30
US201261665686P 2012-06-28 2012-06-28
US61/665,686 2012-06-28
PCT/US2012/067353 WO2013082463A2 (en) 2011-11-30 2012-11-30 Assays, antibodies, immunogens and compositions related to 5-fu

Publications (2)

Publication Number Publication Date
JP2015502356A JP2015502356A (ja) 2015-01-22
JP2015502356A5 true JP2015502356A5 (https=) 2016-01-21

Family

ID=48536238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014544935A Pending JP2015502356A (ja) 2011-11-30 2012-11-30 5−fuに関連するアッセイ、抗体、免疫原および組成物

Country Status (6)

Country Link
US (1) US9702869B2 (https=)
EP (1) EP2785736A4 (https=)
JP (1) JP2015502356A (https=)
AU (1) AU2012327223A1 (https=)
CA (1) CA2857645A1 (https=)
WO (1) WO2013082463A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10401368B2 (en) 2014-03-20 2019-09-03 Pdl Biopharma, Inc. Antibodies and methods for the detection of cell death
US11305010B2 (en) * 2016-01-21 2022-04-19 The Scripps Research Institute Synthetic opioid vaccine
JP6218916B1 (ja) * 2016-12-28 2017-10-25 Jsr株式会社 磁性粒子分散液
JP7104911B2 (ja) * 2018-01-31 2022-07-22 国立研究開発法人産業技術総合研究所 標的物質検出方法及び導波モードセンサ
CN111875587B (zh) * 2020-07-23 2021-07-13 湖南苏阳医疗科技有限公司 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用
WO2022119937A1 (en) * 2020-12-03 2022-06-09 Ortho-Clinical Diagnostics, Inc. Lithium heparin as a blocking agent
CN113501877A (zh) * 2021-08-23 2021-10-15 苏州科铭生物技术有限公司 抗5-氟尿嘧啶单克隆抗体的制备方法、5-氟尿嘧啶的酶联免疫检测方法
CN114487059B (zh) * 2021-12-29 2022-11-25 苏州大学 一种电化学发光免疫传感器及其制备和应用
JP7709140B2 (ja) * 2022-03-01 2025-07-16 学校法人早稲田大学 小型非荷電分子の検出方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366862A (en) * 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
US20030017147A1 (en) 1996-09-20 2003-01-23 Guy L Reed Composition and method for enhancing fibrinolysis
DE10020376A1 (de) * 2000-04-26 2001-11-08 Inst Zelltechnologie E V Dynamische Marker
WO2006044643A2 (en) * 2004-10-15 2006-04-27 Seattle Genetics, Inc. Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
US20060177883A1 (en) 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
AU2008330125B2 (en) * 2007-11-21 2012-11-22 Amgen Inc. Wise binding antibodies and epitopes
CN101461948B (zh) * 2009-01-04 2011-12-14 广东药学院 一种叶酸介导的5-氟尿嘧啶白蛋白大分子前体药物及其制备方法和应用
AU2010222942B2 (en) 2009-03-10 2013-01-10 Baylor Research Institute Anti-CD40 antibodies and uses thereof
CN102770457A (zh) * 2009-03-10 2012-11-07 贝勒研究院 靶向抗原呈递细胞的疫苗
CA2685842A1 (en) * 2009-07-16 2011-01-16 University College Cork, National University Of Ireland, Cork A method for the treatment of cancer
CA2768488A1 (en) 2009-07-17 2011-01-20 Myriad Genetics, Inc. Method of assaying 5-fu
ES2724975T3 (es) * 2009-12-10 2019-09-18 Regeneron Pharma Ratones que producen anticuerpos de cadena pesada

Similar Documents

Publication Publication Date Title
JP2015502356A5 (https=)
JP6715770B2 (ja) モノクローナル抗tk1抗体
JP2020534830A5 (https=)
JP2024054251A (ja) ヒト成長分化因子15(gdf-15)の阻害剤及び免疫チェックポイントブロッカーを使用する併用療法
JP2015535828A5 (https=)
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
RU2018108048A (ru) Новые анти-pd-1 антитела
JP2013518903A5 (https=)
FI2897981T3 (fi) Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä
JP2021511811A5 (https=)
JP2014516540A5 (https=)
JP2016509585A5 (https=)
RU2012131671A (ru) Способ полипептидной модификации для очистки полипептидных мультимеров
JP2014518883A5 (https=)
US9702869B2 (en) Assays, antibodies, immunogens and compositions related to 5-FU
RU2015129720A (ru) Антитела к h7cr
RU2014146707A (ru) Антитела против тофацитиниба и их применение для лекарственного мониторинга
JP2013531655A5 (https=)
Liu et al. Development and evaluation of a novel in situ target-capture approach for aptamer selection of human noroviruses
AU2018378517B2 (en) Kit and method for quantitative detecting HBsAg
JP2014518624A5 (https=)
JP2020515286A5 (https=)
CN112279917B (zh) 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd138的单克隆抗体
JP2008546716A5 (https=)
JP2023539279A (ja) 抗体を産生するための方法